Name: Cerivastatin sodium
Price: Inquiry

- Overview
  - Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Enzyme Modulators
    
    Alternative Name
    
    (3R,5S,6E)-7-[4-(4-Fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt; Ri vastatin, baycol, lipobay
    
    CAS Number
    
    143201-11-0
    
    Molecular Formula
    
    C26H33FNNaO5
    
    Molecular Weight
    
    481.53 g/mol
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Shiomi and Ito (1999). Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits. British Journal of Pharmacology, 126(4): 961–968.
    Cheng-Lai A (2000). Cerivastatin. Heart Disease, 2(1):93-9.
    Zhao et al (2015). Cerivastatin represses atherogenic gene expression through the induction of KLF2 via isoprenoid metabolic pathways. Cellular & Molecular Biology Letters, 20(5):825-39.